Shandong Boan Biotechnology Co., Ltd.

DB:UJ9 Stock Report

Market Cap: €500.0m

Shandong Boan Biotechnology Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of UJ9?
Owner TypeNumber of SharesOwnership Percentage
Institutions2,329,0940.435%
Individual Insiders15,800,0002.95%
Employee Share Scheme21,415,5484%
Private Companies26,223,1204.89%
General Public183,956,62934.3%
Public Companies286,209,30353.4%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 5.2%.


Top Shareholders

Top 12 shareholders own 65.68% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
53.4%
Luye Pharma Group Ltd.
286,209,303€267.0m-20.6%no data
4%
Shandong Boan Biotechnology Co., Ltd, ESOP
21,415,548€20.0m0%no data
2.79%
Yantai Bosheng Investment Center Limited Partnership
14,954,632€14.0m0%no data
2.1%
Yantai Bofa Investment Center Limited Partnership
11,268,488€10.5m0%no data
1.68%
Hua Jiang
9,000,000€8.4m0%no data
1.27%
Changlin Dou
6,800,000€6.3m0%no data
0.3%
Bosera Asset Management Co., Ltd.
1,622,800€1.5m0%0.01%
0.12%
China Asset Management Co. Ltd.
660,042€615.8k-0.09%no data
0.0064%
China Universal Asset Management Company Ltd.
34,200€31.9k0%no data
0.0016%
China Southern Asset Management Co., Ltd.
8,400€7.9k0%no data
0.00067%
E Fund Management Co., Ltd.
3,600€3.4k0%no data
0.00001%
Banca Credinvest SA, Asset Management Arm
52€50.00%no data